Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for ALKS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 4.393B
March 31, 2026 4.258B
December 31, 2025 2.530B
September 30, 2025 2.330B
June 30, 2025 2.253B
March 31, 2025 2.082B
December 31, 2024 2.056B
September 30, 2024 2.155B
June 30, 2024 2.207B
March 31, 2024 2.124B
December 31, 2023 2.136B
September 30, 2023 2.279B
June 30, 2023 2.187B
March 31, 2023 1.923B
December 31, 2022 1.964B
September 30, 2022 1.942B
June 30, 2022 1.957B
March 31, 2022 1.978B
December 31, 2021 2.024B
September 30, 2021 1.995B
June 30, 2021 1.938B
March 31, 2021 1.878B
December 31, 2020 1.950B
September 30, 2020 1.877B
June 30, 2020 1.802B
Date Value
March 31, 2020 1.826B
December 31, 2019 1.805B
September 30, 2019 1.758B
June 30, 2019 1.752B
March 31, 2019 1.757B
December 31, 2018 1.825B
September 30, 2018 1.761B
June 30, 2018 1.751B
March 31, 2018 1.737B
December 31, 2017 1.797B
September 30, 2017 1.748B
June 30, 2017 1.731B
March 31, 2017 1.730B
December 31, 2016 1.726B
September 30, 2016 1.707B
June 30, 2016 1.785B
March 31, 2016 1.795B
December 31, 2015 1.856B
September 30, 2015 1.881B
June 30, 2015 1.915B
March 31, 2015 1.925B
December 31, 2014 1.921B
September 30, 2014 1.838B
June 30, 2014 1.858B
March 31, 2014 1.835B

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Amarin Corp. Plc 624.36M
Jazz Pharmaceuticals Plc 11.08B
Prothena Corp. Plc 302.58M
ACADIA Pharmaceuticals, Inc. 1.743B
Biogen, Inc. 32.09B

Total Assets (Quarterly) Related Metrics